<DOC>
	<DOCNO>NCT02067390</DOCNO>
	<brief_summary>Acute renal injury common complication critical illness . Drug induce renal insult compound degree injury many patient , great deal research focus prevention complication . Traditional biomarkers renal injury like serum creatinine blood urea nitrogen content fail consistently predict harm among patient risk . Kidney Injury Molecule 1 ( KIM-1 ) study biomarker renal injury .</brief_summary>
	<brief_title>Urinary KIM-1 After Vancomycin Linezolid Administration</brief_title>
	<detailed_description>see</detailed_description>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Eligible patient male female adult ≥18 year age expect hospital stay least 48 hour . Eligible patient already prescribe intravenous vancomycin linezolid per primary care provider standard care dosed manner consistent current institutional practice . Receipt antibiotics investigational . Exclusion criterion include patient stage 3or great Chronic Kidney Disease acute kidney injury prior start intravenous vancomycin therapy , patient receive one dose IV vancomycin linezolid total , well patient potentially alter pharmacokinetic parameter ( pregnant patient , burn patient , morbidly obese ( BMI ≥ 40 kg/m2 ) . Additionally , patient exclude receive 1 concurrent nephrotoxic medication within prior 72 hour , receive intravenous contrast within 120 hour randomization , exhibit baseline hematuria , baseline proteinuria . A list concurrent nephrotoxin would exclude patient study provide Appendix C. Age Range : ≥18 year age , age &gt; 90 report &gt; 90 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>